Project Grant R24AI191820
Award Date
5/13/25
Completion Date
4/30/30
Dollars Obligated
$623K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Washington, USA
Similar Awards
This federal Project Grant award of $896,136 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support the development of innovative computational tools and best practice recommendations for analyzing HIV-related count outcomes. The key products and services to be delivered through this R21 study include: (1) providing simulation-based best practice recommendations on when and how to use the...
This Project Grant award, totaling $825,988, was granted by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will support research at Yale University and the University of Texas Southwestern Medical Center to leverage spatial data science and extensive social determinants data to reduce HIV incidence across the 57 Ending the HIV Epidemic (EHE) jurisdictions in the United States. The key...
This federal Project Grant award of $793,247 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to improve the health of people living with HIV. The key objectives are to: Develop and implement a data-driven algorithm to assign validated causes of hospitalizations among people with HIV, and estimate trends and patterns in cause-specific hospitalization rates. Develop hospitalization...
This $815,573 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to investigate the mechanisms driving persistent inflammation in perinatally HIV-infected adolescents maintained on long-term antiretroviral therapy (ART). The goal is to identify the HIV-induced inflammatory networks and viral factors responsible for this chronic inflammation, which can lead to metabolic, neurocognitive,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $402,731 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. This 5-year grant, which runs from March 1, 2025 to February 28, 2030, aims to increase the number of physician-scientists specializing in reproductive, maternal, and child health by providing training in immunology and infectious disease research. The key objectives of the grant are to: 1)...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant totaling $742,463 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Washington. This grant, titled "Exploiting Glycan Holes and Sequence Diversity of Naturally Occurring HIV Envelope towards the Design of Vaccine Immunogen Panels for Induction of Neutralization Breadth," aims to leverage bioinformatics, artificial intelligence, and in vitro studies to...
This $150,607 National Science Foundation project grant will support a research community development project focused on collaborative research related to knowledge of HIV/AIDS. Led by the University of Washington with a completion date of August 2026, the project aims to bring together social scientific and humanistic scholars within the interdisciplinary field of science and technology studies. Key activities over the three-year period will include organizing three annual workshops around...
This $820,845 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine will support a collaborative research project with the Shelby County Health Department to inform policy decisions for improving HIV outcomes across diverse settings. The project will use mathematical modeling to simulate ways to optimize the distribution of interventions, such as long-acting...
This $231,752 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support research at the Fred Hutchinson Cancer Center in Seattle, Washington to investigate the in vivo innate immune response to HIV-1 infection. The key objectives are to: 1) identify the cellular sources of cytokines released during acute HIV-1 infection and determine how each cell type functionally impacts the...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,800,000 Cooperative Agreement under the HIV Prevention Activities Health Department Based program (CFDA 93.940) to Public Health-Seattle & King County in Washington. The funding will support activities to increase the number of patients served at the agency's Sexual Health Clinics and improve the services they provide. Key goals include strengthening the clinic's infrastructure, improving service delivery to address the...